GlassScriptPhysician profile
Avik Sarkar
NPI 1528383403
$7,966.89
in general payments reported to CMS, 2019-2025
22 companies · $1,366 in 2025
The $1,366 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $615 · 2020: $138 · 2021: $1,345 · 2022: $776 · 2023: $2,887 · 2024: $839 · 2025: $1,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,593 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,592.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,531.81 | 2019-2025 | Axios, Spyglass, Overstitch Nxt Endoscopic Suturing System |
| Apollo Endosurgery US INC | $1,029.87 | 2019-2023 | Overstitch Endoscopic Suturing System |
| Ambu INC. | $656.01 | 2021-2025 | |
| Medtronic, INC. | $511.05 | 2021-2025 | Endoflip, Prodigi, Nexpowder |
| Steris Corporation | $393.61 | 2019-2025 | |
| Pentax of America, INC. | $393.59 | 2021-2025 | Inspira, Pentax Medical, C2 Cryoballoon |
| Cook Medical LLC | $328.20 | 2021-2023 | Fusion, Hemospray |
| Fujifilm Healthcare Americas Corporation | $296.26 | 2022-2023 | Fujifilm |
| Abbvie INC. | $208.31 | 2020-2024 | |
| Evoendo, INC | $118.56 | 2025 | |
| Conmed Corporation | $95.69 | 2023 | Conmed Biliary |
| Olympus America INC. | $82.19 | 2023 | Evis Exera Lll Colonovideoscope |
| Celltrion USA INC. | $57.45 | 2024-2025 | Vegzelma |
| Novo Nordisk INC | $46.73 | 2023-2025 | Wegovy |
| Baxter Healthcare | $40.36 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $36.33 | 2025 | Uplizna |
| Aimmune Therapeutics, INC. | $31.60 | 2024 | |
| Phathom Pharmaceuticals, INC. | $29.84 | 2024 | Voquezna |
| Digestive Care, INC. | $29.18 | 2024 | Pertzye |
| Covidien LP | $18.00 | 2020 | |
| Pfizer INC. | $16.43 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.82 | 2024 | Xifaxan, Plenvu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avik Sarkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.